(secondQuint)Tramadol Hydrochloride and Dexketoprofen Trometamol for the Oral Treatment of Moderate to Severe Acute Pain Following Removal of Impacted Lower Third Molar.

 The present phase IV study is a randomised, double-blind, placebo and active-controlled, parallel group study in moderate to severe acute pain after removal of impacted lower third molar.

 In this single-dose clinical trial patients are randomized to the following 3 treatment arms in a 2:2:1 ratio: - TRAM.

HCL/DKP.

TRIS - Paracetamol/TRAM.

HCL - Placebo.

.

 Tramadol Hydrochloride and Dexketoprofen Trometamol for the Oral Treatment of Moderate to Severe Acute Pain Following Removal of Impacted Lower Third Molar@highlight

The study is aimed to evaluate the analgesic efficacy of TRAM.

HCl/DKP.

TRIS 75mg/25mg oral fixed drug combination in comparison with TRAM.

HCl /paracetamol 75mg/650mg in the treatment of moderate to severe acute pain.

